Pediatric Cancer Models in Zebrafish

Trends Cancer. 2020 May;6(5):407-418. doi: 10.1016/j.trecan.2020.02.006. Epub 2020 Mar 13.

Abstract

Pediatric cancer is a leading cause of death in children and adolescents. Improvements in pediatric cancer treatment that include the alleviation of long-term adverse effects require a deeper understanding of the genetic, epigenetic, and developmental factors driving these cancers. Here, we review how the unique attributes of the zebrafish model system in embryology, imaging, and scalability have been used to identify new mechanisms of tumor initiation, progression, and relapse and for drug discovery. We focus on zebrafish models of leukemias, neural tumors and sarcomas - the most common and difficult childhood cancers to treat.

Keywords: brain tumors; cancer; leukemia; pediatric; sarcoma; zebrafish.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Carcinogenesis / genetics
  • Carcinogenesis / pathology
  • Child
  • Disease Models, Animal*
  • Embryo, Nonmammalian
  • High-Throughput Screening Assays / methods*
  • Humans
  • Intravital Microscopy
  • Mice
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Oncogenes / genetics
  • Time Factors
  • Xenograft Model Antitumor Assays
  • Zebrafish*

Substances

  • Antineoplastic Agents